Publications

Sort by: [ Author  (Asc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
Baptista, Pedro V., Gonçalo Doria, Pedro Quaresma, Miguel Cavadas, Cristina S. Neves, Inês Gomes, Peter Eaton, Eulália Pereira, and Ricardo Franco. "Nanoparticles in molecular diagnostics. Nanoparticles in Translational Science and Medicine." In Progress in Molecular Biology and Translational Science, edited by A. Villaverde and Michael P. Conn. Elsevier, 2012.
Beola, L., L. Asín, C. Roma-Rodrigues, Y. Fernández-Afonso, R. M. Fratila, D. Serantes, S. Ruta, R. W. Chantrell, A. R. Fernandes, P. V. Baptista, J. M. de la Fuente, V. Grazú, and L. Gutiérrez. "The Intracellular Number of Magnetic Nanoparticles Modulates the Apoptotic Death Pathway after Magnetic Hyperthermia Treatment." ACS Appl Mater Interfaces 12 (2020): 43474-43487. AbstractWebsite

n/a

Bernacka-Wojcik, Iwona, Susana Ribeiro, Pawel Jerzy Wojcik, Pedro Urbano Alves, Tito Busani, Elvira Fortunato, Pedro Viana Baptista, Jose Antonio Covas, Hugo Aguas, Loic Hilliou, and Rodrigo Martins. "Experimental optimization of a passive planar rhombic micromixer with obstacles for effective mixing in a short channel length." Rsc Advances 4 (2014): 56013-56025. Abstract

n/a

Bernacka-Wojcik, Iwona, Susana Ribeiro, Pawel Jerzy Wojcik, Pedro Urbano Alves, Tito Busani, Elvira Fortunato, Pedro Viana Baptista, José António Covas, Hugo Águas, Loic Hilliou, and Rodrigo Martins. " Experimental optimization of a passive planar rhombic micromixer with obstacles for effective mixing in a short channel length." RSC ADVANCES 4 (2014). AbstractWebsite

This paper presents the performance of a passive planar rhombic micromixer with diamond-shaped obstacles and a rectangular contraction between the rhombi. The device was experimentally optimized using water for high mixing efficiency and a low pressure drop over a wide range of Reynolds numbers (Re = 0.1–117.6) by varying geometrical parameters such as the number of rhombi, the distance between obstacles and the contraction width. Due to the large amount of data generated, statistical methods were used to facilitate and improve the results of the analysis. The results revealed a rank of factors influencing mixing efficiency: Reynolds number > number of rhombi > contraction width > inter-obstacles distance. The pressure drop measured after three rhombi depends mainly on Re and inter-obstacle distance. The resulting optimum geometry for the low Re regime has a contraction width of 101 μm and inter-obstacles distance of 93 μm, while for the high Re regime a contraction width of 400 μm and inter-obstacle distance of 121 μm are more appropriate. These mixers enabled 80% mixing efficiency creating a pressure drop of 6.0 Pa at Re = 0.1 and 5.1 × 104 Pa at Re = 117.6, with a mixer length of 2.5 mm. To the authors' knowledge, the developed mixer is one of the shortest planar passive micromixers reported to date.

Bernacka-Wojcik, Iwona, Rohan Senadeera, Pawel Jerzy Wojcik, Leonardo Bione Silva, Gonçalo Doria, Pedro Baptista, Hugo Aguas, Elvira Fortunato, and Rodrigo Martins. "Inkjet printed and "doctor blade" TiO2 photodetectors for DNA biosensors." Biosens. Bioelectron. 25 (2010): 1229-1234.
Bernacka-Wojcik, Iwona, Hugo Aguas, Fabio Ferreira Carlos, Paulo Lopes, Pawel Jerzy Wojcik, Mafalda Nascimento Costa, Bruno Veigas, Rui Igreja, Elvira Fortunato, Pedro Viana Baptista, and Rodrigo Martins. "Single Nucleotide Polymorphism Detection Using Gold Nanoprobes and Bio-Microfluidic Platform With Embedded Micro lenses." Biotechnology and Bioengineering 112 (2015): 1210-1219. Abstract

n/a

Bernacka-Wojcik, Iwona, Paulo Lopes, Ana Catarina Vaz, Bruno Veigas, Pawel Jerzy Wojcik, Pedro Simões, David Barata, Elvira Fortunato, Pedro V. Baptista, Hugo Águas, and Rodrigo Martins. "Bio-microfluidic platform for gold nanoprobe based DNA detection—application to Mycobacterium tuberculosis." Biosens Bioelectron 48 (2013): 87-93. AbstractWebsite

We have projected and fabricated a microfluidic platform for DNA sensing that makes use of an optical colorimetric detection method based on gold nanoparticles. The platform was fabricated using replica moulding technology in PDMS patterned by high-aspect-ratio SU-8 moulds. Biochips of various geometries were tested and evaluated in order to find out the most efficient architecture, and the rational for design, microfabrication and detection performance is presented. The best biochip configuration has been successfully applied to the DNA detection of Mycobacterium tuberculosis using only 3 µl on DNA solution (i.e. 90 ng of target DNA), therefore a 20-fold reduction of reagents volume is obtained when compared with the actual state of the art.

Branquinho, R., B. Veigas, J. V. Pinto, R. Martins, E. Fortunato, and P. V. Baptista. "Real-time monitoring of PCR amplification of proto-oncogene c-MYC using a Ta₂O₅ electrolyte-insulator-semiconductor sensor." Biosens Bioelectron 28 (2011): 44-9. AbstractWebsite

n/a

Branquinho, R., J. V. Pinto, T. Busani, P. Barquinha, L. Pereira, P. V. Baptista, R. Martins, and E. Fortunato. "Plastic Compatible Sputtered Ta2O5 Sensitive Layer for Oxide Semiconductor TFT Sensors." J. Display Technol 9 (2013): 723-728.
C
Cabral, Rita, and Pedro V. Baptista. "THE CHEMISTRY AND BIOLOGY OF GOLD NANOPARTICLE-MEDIATED PHOTOTHERMAL THERAPY: PROMISES AND CHALLENGES." Nano Life 3 (2013): 330001. AbstractWebsite

Under laser radiation, cells labeled with gold nanoparticles (AuNPs) are believed to suffer thermal damage due to the transfer of the absorbed light from the AuNPs to the cells. This process, which involves complex mechanisms such as the rapid electron–phonon decay in the AuNPs, followed by phonon–phonon relaxation, culminates in the localized heating of both the AuNPs and the cells, setting the rational for the use of these nanostructures, under laser light, in cancer photothermal therapy (PTT). Here, we discuss the chemical and biological aspects of this promising new therapeutic approach, including the advantages over conventional cancer therapies and the challenges that scientists still need to overcome to progress toward translation research

Cabral, Rita M., and Pedro V. Baptista. "Anti-cancer precision theranostics: a focus on multifunctional gold nanoparticles." Expert Review of Molecular Diagnostics 14 (2014): 1041-1052. Abstract

n/a

Carlos, F. F., J. Silva-Nunes, O. Flores, M. Brito, G. Doria, L. Veiga, and P. V. Baptista. "Association of FTO and PPARG polymorphisms with obesity in Portuguese women." Diabetes Metab Syndr Obes 6 (2013): 241-5. AbstractWebsite

n/a

Carlos, Fabio Ferreira, Jose Silva-Nunes, Orfeu Flores, Miguel Brito, Goncalo Doria, Luisa Veiga, and Pedro Viana Baptista. "Association of FTO and PPARG polymorphisms with obesity in Portuguese women." Diabetes, metabolic syndrome and obesity : targets and therapy 6 (2013): 241-5. Abstract

n/a

Carlos, Fábio Ferreira, Orfeu Flores, Gonçalo Doria, and Pedro Viana Baptista. "Characterization of genomic SNP via colorimetric detection using a single gold nanoprobe." Analytical Biochemistry 465 (2014): 1-5. AbstractWebsite

Identification of specific nucleic acid sequences mediated by gold nanoparticles derivatized thiol-modified oligonucleotides (Au-nanoprobes) has been proven to be a useful tool in molecular diagnostics. Here, we demonstrate that, on optimization, detection may be simplified via the use of a single Au-nanoprobe to detect a single nucleotide polymorphism (SNP) in homo- or heterozygote condition. We validated this non-cross-linking approach through the analysis of 20 clinical samples using a single specific Au-nanoprobe for an SNP in the FTO (fat mass and obesity-associated) gene against direct DNA sequencing. Sensitivity, specificity, and limit of detection (LOD) were determined, and statistical differences were calculated by one-way analysis of variance (ANOVA) and a post hoc Tukey's test to ascertain whether there were any differences between Au-nanoprobe genotyped groups. For the first time, we show that the use of a single Au-nanoprobe can detect SNP for each genetic status (wild type, heterozygous, or mutant) with high degrees of sensitivity (87.50%) and specificity (91.67%).

Carlos, F. F., B. Veigas, A. S. Matias, G. Doria, O. Flores, and P. V. Baptista. "Allele specific LAMP- gold nanoparticle for characterization of single nucleotide polymorphisms." Biotechnol Rep (Amst) 16 (2017): 21-25. AbstractWebsite

n/a

Child, Hannah Winifred, Yulan Hernandez, João Conde, Margaret Mullin, Pedro V. Baptista, Jesus Maria de la Fuente, and Catherine C. Berry. "Gold nanoparticle-siRNA mediated oncogene knockdown at RNA and protein level, with associated gene effects." NANOMEDICINE 10 (2015): 2513-2525. AbstractWebsite

Aims: RNAi is a powerful tool for gene silencing that can be used to reduce undesirable overexpression of oncogenes as a novel form of cancer treatment. However, when using RNAi as a therapeutic tool there is potential for associated gene effects. This study aimed to utilize gold nanoparticles to deliver siRNA into HeLa cells. Results: Knockdown of the c-myc oncogene by RNAi, at the RNA, protein and cell proliferation level was achieved, while also identifying associated gene responses. Discussion: The gold nanoparticles used in this study present an excellent delivery platform for siRNA, but do note associated gene changes. Conclusion: The study highlights the need to more widely assess the cell physiological response to RNAi treatment, rather than focus on the immediate RNA levels.

Coelho, Beatriz Jorge, Bruno Veigas, Hugo Aguas, Elvira Fortunato, Rodrigo Martins, Pedro Viana Baptista, and Rui Igreja. "A Digital Microfluidics Platform for Loop-Mediated Isothermal Amplification Detection." Sensors 17 (2017). Abstract

n/a

Coelho, Beatriz, Bruno Veigas, Elvira Fortunato, Rodrigo Martins, Hugo Aguas, Rui Igreja, and Pedro V. Baptista. "Digital Microfluidics for Nucleic Acid Amplification." Sensors 17 (2017). Abstract

n/a

Conde, João, Pedro V. Baptista, Yulan Hernández, Vanesa Sanz, and Jesus M. de la Fuente. "Modification of plasmid DNA topology by ‘histone-mimetic’ gold nanoparticles." Nanomedicine (2012).
Conde, João, Alfredo Ambrosone, Yulán Hernandez, Furong Tian, Mark McCully, Catherine C. Berry, Pedro V. Baptista, and Claudia T. " 15 years on siRNA delivery: Beyond the State-of-the-Art on inorganic nanoparticles for RNAi therapeutics." NANO TODAY In Press (2015). Abstract

RNAi has always captivated scientists due to its tremendous power to modulate the phenotype of living organisms. This natural and powerful biological mechanism can now be harnessed to down-regulate specific gene expression in diseased cells; opening up endless opportunities. Since most of the conventional siRNA delivery methods are limited by a narrow therapeutic index and significant side and off-target effects, we are now in the dawn of a new age in gene therapy driven by nanotechnology vehicles for RNAi therapeutics. Here, we outlook the "do's and dont's" of the inorganic RNAi nanomaterials developed in the last 15 years and the different strategies employed are compared and scrutinized, offering important suggestions for the next 15.

Conde, Joao, Goncalo Doria, and Pedro Baptista. "Noble metal nanoparticles applications in cancer." Journal of drug delivery 2012 (2012): 751075. Abstract

n/a

Conde, Joao, Chenchen Bao, Daxiang Cui, Pedro V. Baptista, and Furong Tian. "Antibody-drug gold nanoantennas with Raman spectroscopic fingerprints for in vivo tumour theranostics." Journal of Controlled Release 183 (2014): 87-93. Abstract

n/a

Conde, João, Jesus M. de la Fuente, and Pedro V. Baptista. "Nanomaterials for reversion of multidrug resistance in cancer: a new hope for an old idea?" Front. Pharmacol. (2013).
Conde, J., J. M. de la Fuente, and P. V. Baptista. "Nanomaterials for reversion of multidrug resistance in cancer: a new hope for an old idea?" Front Pharmacol 4 (2013): 134. AbstractWebsite

n/a

Conde, Joao, Furong Tian, Jesus M. de la Fuente, and Pedro V. Baptista. "Editorial: Cancer Nanotheranostics: What Have We Learned So Far?" Frontiers in Chemistry 71 (2016).Website